NDC 58602-844

NDC codes

FDA NDC Directory

Product NDC (as listed)58602-844Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58602-0844Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
58602-844-60	58602084460	1 BLISTER PACK in 1 CARTON (58602-844-60) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Apr 17, 2025
58602-844-66	58602084466	2 BLISTER PACK in 1 CARTON (58602-844-66) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Apr 17, 2025
58602-844-85	58602084485	3 BLISTER PACK in 1 CARTON (58602-844-85) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Apr 17, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
Generic name (nonproprietary): fexofenadine hydrochloride and pseudoephedrine hydrochloride
Active ingredients: Fexofenadine hydrochloride — 180 mg/1Pseudoephedrine hydrochloride — 240 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Aurohealth LLC
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215232
Marketing start: Apr 17, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 58602-844_bced0a2e-047e-456e-bbd2-495e83bf07eeSPL ID bced0a2e-047e-456e-bbd2-495e83bf07eeSPL set ID bced0a2e-047e-456e-bbd2-495e83bf07eeRxCUI 997415UNII 2S068B75ZU, 6V9V2RYJ8N
Pharmacologic class: Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N458602084460 followed by a unit qualifier and the quantity

Package 58602-0844-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 18, 2025.

Indications (excerpt from the label)

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily restores freer breathing through the nose

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215232

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215232
Product	Strength	Form · route	Labeler	Product NDC
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	Fexofenadine hydrochloride 180 mg/1; Pseudoephedrine hydrochloride 240 mg/1	Tablet, Film coated, Extended releaseOral	WALGREEN CO.	0363-0270

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride NDC 58602-844